// EFFECTIVE UNTIL SEPTEMBER 30, 2023 PER CHAPTER 532 OF 2019 //
(a) Beginning January 1, 2020, the Department shall establish a medication–assisted treatment program that utilizes at least one formulation of each FDA–approved full opioid agonist, partial opioid agonist, and long–acting opioid antagonists used for the treatment of opioid use disorders in the Baltimore Pre–trial Complex.
(b) Funding for the program shall be as provided in the State budget.
(c) The Department shall, in consultation with its head of medical treatment services, determine whether the program is capable of being administered in existing structures of the Baltimore Pre–trial Complex.
Structure Maryland Statutes
Title 9 - State and Local Correctional System -- Inmates
Section 9-601 - Pregnant Inmates
Section 9-601.1 - Involuntary Placement of Pregnant Inmate in Restrictive Housing
Section 9-602.1 - Investigation of Death of Inmate
Section 9-603 - Methadone Detoxification Program
Section 9-603.1 - Medication-Assisted Treatment Program
Section 9-604 - Payment of Burial and Funeral Expenses of Indigent Inmates
Section 9-605 - Liability of Estate of Inmate for Damages and Expenses
Section 9-606 - Medical Treatment for Juvenile Inmates
Section 9-607 - Investigation of State Correctional Facilities by Grand Juries
Section 9-608 - Visitation of Local Correctional Facilities by Grand Juries
Section 9-609 - Release Date; Saturday, Sunday or Holiday
Section 9-609.1 - Identification Cards for Released Inmates
Section 9-610 - Construction of Penalty Provision
Section 9-611 - Copy of the Warrant or Detainer
Section 9-612 - Medication for Mental Illness
Section 9-613 - Counseling and Referral of Inmates With Hepatitis C
Section 9-614 - Restrictive Housing Reports
Section 9-614.1 - Placing Minor in Restrictive Housing
Section 9-615 - Management of Inmate Earnings
Section 9-616 - Menstrual Hygiene Products for Female Inmates